{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:19:57Z","timestamp":1771654797226,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,10]]},"DOI":"10.7759\/cureus.69090","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T13:47:38Z","timestamp":1725976058000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Acquired Factor V Inhibitor During Bullous Pemphigoid Treatment"],"prefix":"10.7759","author":[{"given":"Kaho","family":"Ou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuko","family":"Matsukura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt E","year":"2013","unstructured":"Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013, 381:320-32. 10.1016\/S0140-6736(12)61140-4","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S19433","article-title":"Anti-factor V inhibitor in patients with autoimmune diseases: case report and literature review","volume":"4","author":"Imashuku S","year":"2011","unstructured":"Imashuku S, Hasegawa T, Kubo K, Nakato M, Shima M. Anti-factor V inhibitor in patients with autoimmune diseases: case report and literature review. Int Med Case Rep J. 2011, 4:31-4. 10.2147\/IMCRJ.S19433","journal-title":"Int Med Case Rep J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.61.791","article-title":"Acquired factor V inhibitor (Article in Japanese)","volume":"61","author":"Yamada S","year":"2020","unstructured":"Yamada S, Asakura H. Acquired factor V inhibitor (Article in Japanese). Rinsho Ketsueki. 2020, 61:791-8. 10.11406\/rinketsu.61.791","journal-title":"Rinsho Ketsueki"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.26420\/annhematoloncol.2017.1168","article-title":"Acquired factor V inhibitors: a review of literature","volume":"4","author":"Boland F","year":"2017","unstructured":"Boland F, Shreenivas AV. Acquired factor V inhibitors: a review of literature. Ann Hematol Oncol. 2017, 4:1168. 10.26420\/annhematoloncol.2017.1168","journal-title":"Ann Hematol Oncol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.122.5.2119","article-title":"A monoclonal IgG4 (lambda) with factor V inhibitory activity","volume":"122","author":"Hurtubise PE","year":"1979","unstructured":"Hurtubise PE, Coots MC, Jacob DJ, Muhleman AF, Glueck HI. A monoclonal IgG4 (lambda) with factor V inhibitory activity. J Immunol. 1979, 122:2119-21.","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.2340\/0001555572245249","article-title":"Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation","volume":"72","author":"Suzuki M","year":"1992","unstructured":"Suzuki M, Harada S, Yaoita H. Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation. Acta Derm Venereol. 1992, 72:245-9.","journal-title":"Acta Derm Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2009.0672","article-title":"Favourable progression of acquired hemophilia-associated bullous pemphigoid","volume":"19","author":"Caudron A","year":"2009","unstructured":"Caudron A, Chatelain D, Christophe O, Lok C, Roussel B, Viseux V. Favourable progression of acquired hemophilia-associated bullous pemphigoid. Eur J Dermatol. 2009, 19:383-4. 10.1684\/ejd.2009.0672","journal-title":"Eur J Dermatol"},{"key":"ref8","article-title":"Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid","volume":"96","author":"Zhang GS","year":"2006","unstructured":"Zhang GS, Zuo WL, Dai CW, Xu YX, Shen JK, Luo YY, Yi Y. Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid. Thromb Haemost. 2006, 96:692-4.","journal-title":"Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-09-0596","article-title":"Acquired haemophilia A associated with transitory and severe factor V deficiency during bullous pemphigoid: first report","volume":"101","author":"Ryman A","year":"2009","unstructured":"Ryman A, Hubiche T, Amiral J, Ta\u00efeb A, Guerin V. Acquired haemophilia A associated with transitory and severe factor V deficiency during bullous pemphigoid: first report. Thromb Haemost. 2009, 101:582-3. 10.1160\/TH08-09-0596","journal-title":"Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18888\/hi.0000003531","article-title":"A case of acquired hemophilia A occurring during treatment for bullous pemphigoid","volume":"64","author":"Reina S","year":"2022","unstructured":"Reina S, Haruhi Y, Hidenobu S, Keishiro T. A case of acquired hemophilia A occurring during treatment for bullous pemphigoid. Rinsho Derma. 2022, 64:1657-61. 10.18888\/hi.0000003531","journal-title":"Rinsho Derma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000499525","article-title":"Bullous pemphigoid associated with acquired hemophilia A: a case report and review of the literature","volume":"11","author":"Fakprapai W","year":"2019","unstructured":"Fakprapai W, Wattanakrai P. Bullous pemphigoid associated with acquired hemophilia A: a case report and review of the literature. Case Rep Dermatol. 2019, 11:130-9. 10.1159\/000499525","journal-title":"Case Rep Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242346-a-case-of-acquired-factor-v-inhibitor-during-bullous-pemphigoid-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T13:47:46Z","timestamp":1725976066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242346-a-case-of-acquired-factor-v-inhibitor-during-bullous-pemphigoid-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.69090","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}